| Literature DB >> 32848183 |
Su-Mei Tsai1, Kuo-Chang Chu1, Yun-Jin Jiang2,3,4,5,6.
Abstract
Mutations of the Gon4l/udu gene in different organisms give rise to diverse phenotypes. Although the effects of Gon4l/Udu in transcriptional regulation have been demonstrated, they cannot solely explain the observed characteristics among species. To further understand the function of Gon4l/Udu, we used yeast two-hybrid (Y2H) screening to identify interacting proteins in zebrafish and mouse systems, confirmed the interactions by co-immunoprecipitation assay, and found four novel Gon4l-interacting proteins: BRCA1 associated protein-1 (Bap1), DNA methyltransferase 1 (Dnmt1), Tho complex 1 (Thoc1, also known as Tho1 or HPR1), and Cryptochrome circadian regulator 3a (Cry3a). Furthermore, all known Gon4l/Udu-interacting proteins-as found in this study, in previous reports, and in online resources-were investigated by Phenotype Enrichment Analysis. The most enriched phenotypes identified include increased embryonic tissue cell apoptosis, embryonic lethality, increased T cell derived lymphoma incidence, decreased cell proliferation, chromosome instability, and abnormal dopamine level, characteristics that largely resemble those observed in reported Gon4l/udu mutant animals. Similar to the expression pattern of udu, those of bap1, dnmt1, thoc1, and cry3a are also found in the brain region and other tissues. Thus, these findings indicate novel mechanisms of Gon4l/Udu in regulating CpG methylation, histone expression/modification, DNA repair/genomic stability, and RNA binding/processing/export.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32848183 PMCID: PMC7449961 DOI: 10.1038/s41598-020-70855-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic structures of the bait proteins. Domain structures of (a) zebrafish Udu and (b) mouse GON4L. Black lines indicate locations of bait used in this study.
Zebrafish Udu-binding proteins isolated by yeast two-hybrid analysis.
| Category | Bait | PBS* | Prey binding region | Symbol | Name (accession number) | GO terms |
|---|---|---|---|---|---|---|
| Lipid metabolism-related | 1 | D | unknown-3786 | Apobb.1 | Apolipoprotein Bb, tandem duplicate 1 (apobb.1), mRNA (NM_001030062.1 ) | Lipid transporter activity |
| 1 | D | − 1 ~ 399 | Ephx2 | Epoxide hydrolase 2, cytoplasmic, transcript variant X1, mRNA (XM_021467153.1) | Epoxide hydrolase activity | |
| Transcriptional regulation | 1 | D | 432 ~ 1,248 | Pax7b | Paired box 7b (NM_001146149.1) | Sequence-specific DNA binding |
| 2 | D | 92 ~ 652 | Hoxc4a | Homeobox C4a, mRNA (NM_131122.2) | Sequence-specific DNA binding | |
| 1 | D | 96 ~ 600 | Otx1 | Orthodenticle homeobox 1, mRNA (NM_131250.2) | Sequence-specific DNA binding | |
| 1 | D | − 1 ~ 954 | Cry3a | Cryptochrome circadian regulator 3a, transcript variant 1, mRNA (NM_001313822.1) | Negative regulation of transcription; sequence-specific DNA binding | |
| 2 | D | − 7 ~ 754 | Pelp1 | Proline, glutamate and leucine rich protein 1, mRNA (XM_001338982.7) | Transcription factor binding; chromatin binding | |
| RNA-binding/processing | 1 | D | 2094 ~ 2,781 | Heatr6 | HEAT repeat containing 6 (NM_001114313.1) | RNA binding |
| 2 | D | − 1 ~ 614 | Fbrsl1 | Fibrosin-like 1 protein variant 1a mRNA, complete cds, alternatively spliced (KY492379.1) | RNA binding | |
| 2 | D | − 1 ~ 1,026 | Rbmx2 | RNA binding motif protein X-linked 2, mRNA (NM_001025166.1) | RNA binding | |
| Apoptosis/Cell proliferation/DNA replication | 2 | D | 1,155 ~ 1893 | Mcm3 | Minichromosome maintenance complex component 3, mRNA (NM_212567.2) | DNA replication origin binding; helicase activity |
| 2 | D | 1971 ~ 2,229 | Mcm4 | minichromosome maintenance complex component 4, mRNA (NM_198913.2) | DNA replication origin binding; helicase activity | |
| 1 | D | − 1 ~ 1,355 | Bnipl | BCL2/adenovirus E1B 19kD interacting protein, like, transcript variant X1, mRNA (XM_009292526.3) | Exopolyphosphatase activity | |
| 2 | D | 270 ~ 1744 | Gulp1b | GULP, engulfment adaptor PTB domain containing 1b, transcript variant X5, mRNA (XM_001345116.6) | Apoptotic process | |
| 2 | D | 135 ~ 706 | Gpatch11 | G patch domain containing 11, mRNA; zgc92714 (NM_001002393.1) | Nucleic acid binding | |
| Signaling pathways | 1 | D | 1,356 ~ unknown | Dlc | deltaC, mRNA (NM_130944.1) | PDZ domain binding; Notch binding |
| 1 | D | Unknown ~ 1,216 | Napba | N-ethylmaleimide-sensitive factor attachment protein, beta, mRNA (NM_001020655.2) | Soluble NSF attachment protein activity; syntaxin binding | |
| 2 | D | 2,640 ~ 3,309 | Dock6 | Danio rerio dedicator of cytokinesis 6, transcript variant X1, misc_RNA (XR_660514.3) | Guanyl-nucleotide exchange factor activity | |
| Protein translocation/ processing | 1 | D | Unknown ~ 915 | Ssr1 | Signal sequence receptor, alpha, mRNA (NM_201327.1) | Cellular response to estrogen |
| 1 | D | − 1 ~ 559 | Naa15b | N(alpha)-acetyltransferase 15, NatA auxiliary subunit b, mRNA (NM_203321.2) | Peptide alpha-N-acetyltransferase activity | |
| Cytoskeleton | 1 | D | − 1 ~ 628 | Agrn | Agrin, mRNA (NM_001177452.1) | Serine-type endopeptidase inhibitor activity |
| 1 | D | − 1 ~ 608 | Pleca | plectin a, mRNA (NM_001100032.1) | Ankyrin binding; actin binding | |
| 1 | D | 147 ~ 841 | Actc1 | cardiac muscle alpha actin 1 (NM_001002066.1) | Nucleotide binding; ATP binding | |
| 2 | D | − 1 ~ unknown | Neb | Nebulin (neb), transcript variant X41, mRNA (XM_021474182.1) | Actin filament binding | |
| 2 | D | − 1 ~ unknown | Cnn3b | Calponin 3, acidic b, mRNA (NM_001024073.1) | Actin binding; calmodulin binding | |
| Others | 1 | D | 225 ~ 661 | Slc25a3b | Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3b, mRNA (NM_213722.1) | Inorganic phosphate transmembrane transporter activity |
*PBS is a score that is automatically computed through algorithms; D means “moderate confidence in the interaction”.
Mouse GON4L-binding proteins isolated by yeast two-hybrid analysis.
| Category | Bait | Prey binding region | Prey library | Symbol | Name (accession number) | GO terms |
|---|---|---|---|---|---|---|
| Lipid metabolism-related | 3 | 16 ~ 240 | Mouse embryo | GC | Group specific component (NM_008096) | Vitamin D-binding; vitamin transmembrane transporter activity |
| 3 | − 3 ~ 374 − 13 ~ 97 3 ~ 374 | Mouse B cell/Cardiac cell | LIAS | Lipoic acid synthetase, mitochondrial protein (NM_024471) | Lipoate synthase activity; transferase activity | |
| Transcriptional regulation | 3 | 5 ~ 176 | Mouse embryo | FOXA2 | Forkhead box a2 (NM_010446) | DNA-binding transcription factor activity |
| 3 | 189 ~ 547 | Mouse B cell | HIVEP1 | Human Immunodeficiency Virus Type I Enhancer Binding Protein 1 (NM_007772) | DNA-binding transcription factor activity | |
| 3 | 259 ~ 580 | Mouse B cell | ARNTL2 | Aryl hydrocarbon receptor nuclear translocator-like 2, also known as Bmal2 (NM_172309) | DNA-binding transcription factor activity | |
| 3 | 821 ~ 1,006 | Mouse B cell | BRD4 | Bromodomain containing 4 (NM_020508) | Lysine-acetylated histone binding; chromatin binding | |
| 4 | 1,233 ~ 1,421 1,355 ~ 1,421 | Mouse Cardiac cell | NPAT | Nuclear Protein, Ataxia-Telangiectasia Locus (NM_001081152) | Regulation of transcription involved in G1/S transition of mitotic cell cycle; transcription coactivator activity of histones | |
| 3 | 654 ~ 897 | Mouse B cell | CRAMP1L | Cramped-like, cramp1L (NM_020608) | DNA binding; nucleus; chromatin binding | |
| 3 | 591 ~ 726 | Mouse Cardiac cell | SKI | ski sarcoma viral oncogene homolog (NM_011385) | SMAD binding; transcription corepressor activity | |
| 3 | 118 ~ 296 | Mouse B cell | TLE3 | Transducin-Like Enhancer Of Split 3, Homolog Of Drosophila E (NM_009389) | Transcription corepressor activity | |
| RNA-binding/processing | 3 | 338 ~ 532 | Mouse embryo | THOC1 | Tho complex 1, also known as Tho1, HPR1 (NM_153552) | DNA binding; RNA binding; protein binding; nucleus; cytoplasm; mRNA export from nucleus; RNA splicing; replication fork processing |
| 3 | − 6 ~ 126 − 3 ~ 126 8 ~ 97 24 ~ 118 | Mouse Cardiac cell/Mouse embryo | RPS25 | Ribosomal Protein S25 (NM_024266) | Structural constituent of ribosome | |
| 3 | 401 ~ 655 431 ~ 664 435 ~ 711 | Mouse B cell | DDX10 | DEAD-Box Helicase 10 (XM_284494) | RNA binding; RNA helicase activity; ATP binding | |
| 3 | 74 ~ 458 200 ~ 477 26 ~ 479 373 ~ 511 | Mouse B cell/ Mouse embryo | CTNNBL1 | Beta-catenin-like protein 1 (NM_025680) | mRNA splicing via spliceosome; protein binding; positive regulation of apoptotic process | |
| Apoptosis/Cell proliferation/DNA replication | 3 | 625 ~ 729 545 ~ 646 | Mouse B cell/ Mouse embryo | BAP1 | BRCA1-associated protein 1 (NM_027088) | Chromatin binding; thiol-dependent ubiquitinyl hydrolase activity |
| 3 | − 21 ~ 202 | Mouse embryo | CACYBP | Calcyclin binding protein (NM_009786) | Tubulin binding; ubiquitin protein ligase binding; S100 protein binding | |
| 3 | 423 ~ 715 | Mouse Cardiac cell | CIT | Citron Rho-interacting Kinase (NM_007708) | Protein serine/threonine kinase activity; mitotic cytokinesis | |
| 3 | 554 ~ 831 574 ~ 704 | Mouse B cell/Cardiac cell | DNMT1 | DNA methyltransferase 1 (AF162282) | Chromatin binding; DNA (cytosine-5-)-methyltransferase activity | |
| 3 | 254 ~ 656 547 ~ 643 | Mouse B cell/Cardiac cell | KIF20A | rabkinesin-6 (Y09632) | ATPase activity; microtubule motor activity; nucleotide binding | |
| Signaling pathways | 3 | 48 ~ 435 313 ~ 439 339 ~ 446 262 ~ 461 340 ~ 558 250 ~ 465 | Mouse Cardiac cell/ Mouse embryo | GPC1 | Glypican-1 (NM_016696) | Fibroblast growth factor binding |
| 3 | 65 ~ 582 | Mouse embryo | ITSN1 | Intersectin 1 (NM_010587) | Guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; calcium ion binding | |
| 3 | 410 ~ 526 | Mouse embryo | PPP3CB | Protein phosphatase 3, catalytic subunit, beta isoform (NM_008914) | Calmodulin-dependent protein phosphatase activity | |
| 3 | 249 ~ 554 | Mouse B cell | FCHSD2 | FCHSD2/Carom/FCH and double SH3 domains 2/F-BAR And Double SH3 Domains Protein 2 (NM_001146010) | Phosphatidylinositol-3,4,5-trisphosphate binding | |
| 3 | 367 ~ 523 | Mouse Cardiac cell | STAM1 | Signal-Transducing Adaptor Molecule 1 (NM_011484) | Ubiquitin-like protein ligase binding | |
| 3 | 242 ~ 419 251 ~ 419 269 ~ 419 | Mouse B cell/Mouse embryo | ALS2CR2 | STE20-related kinase adapter protein beta; STRADB (NM_172656) | Protein serine/threonine kinase activity; ATP binding | |
| 3 | 4 ~ 209 | Mouse Cardiac cell | TNIP3 | TNFAIP3 Interacting Protein 1, A20-binding inhibitor of NF-κB activation (ABIN-1) (NM_001001495) | Protein deubiquitination; identical protein binding; MAPK binding | |
| 3 | 259 ~ 554 | Mouse B cell | TNIP1 | TNFAIP3 Interacting Protein 3), A20-binding inhibitor of NF-κB activation (ABIN-3) (NM_021327) | Protein deubiquitination; identical protein binding; MAPK binding | |
| Protein processing/translocation | 3 | − 37 ~ 50 | Mouse embryo | AHSA1 | AHA1, Activator of Heat Shock 90 kDa Protein ATPase Homolog 1 (NM_146036) | ATPase activator activity; Hsp90 protein binding; extracellular exosome |
| 3 | 3 ~ 279 52 ~ 279 − 5 ~ 279 14 ~ 279 | Mouse B cell/Cardiac cell/Mouse embryo | C1QBP | Complement component 1 Q subcomponent-binding protein, mitochondrial (NM_007573) | Mitochondrial ribosome binding; mRNA binding; translation activator activity | |
| Others | 3 | 269 ~ 376 302 ~ 383 | Mouse embryo | KLHDC3 | Kelch domain containing 3,transcript 1 (NM_027910) | Chromatin binding; meiotic recombination |
Figure 2Confocal images for the cellular co-localization analysis of Udu and its interacting proteins. For co-localization analysis, Flag-tagged Udu-P/S construct was co-transfected individually with each Myc-tagged construct, including Bap1, Dnmt1, Thoc1, and Cry3a. Anti-FLAG M2 monoclonal antibody and rabbit anti-MYC antibody were used. Alexa Fluor 488-conjugated anti-mouse secondary antibody and Alexa Fluor 564-conjugated anti-rabbit secondary antibody were then applied. Green fluorescence indicates Udu-P/S, while red fluorescence indicates the expression of Myc-tagged proteins. Blue color is DAPI used for nuclear counterstain. Merged images show the nuclear co-localization of Udu and the interacting proteins.
Figure 3Co-immunoprecipitation analysis for the interaction of Udu with Bap1, Dnmt1, Thoc1, and Cry3a. Flag-tagged control or Flag-tagged Udu-expressing constructs were co-transfected with different Myc-tagged candidate Udu-interacting proteins, including Bap1, Dnmt1, Thoc1, and Cry3a. The cell lysate was incubated with anti-FLAG M2 magnetic beads, then subjected to immunoblot with anti-MYC or anti-FLAG antibody. Arrowheads indicate the expected size of full-length Udu. Lanes 1 to 9 were cropped from the same blots, while lanes 10–12 were from the other ones. To observe the expression of full-length Udu, photographs using a longer exposure time of anti-FLAG immunoblots were taken. The original un-cropped immunoblots were shown in Supplementary Fig. S7a and photographs with shorter exposure time for anti-FLAG immunoblots were also included in Supplementary Fig. S7b as supporting information.
List of the most enriched phenotypes and their corresponding Udu/Gon4l-interacting genes after model organism Phenotype Enrichment Analysis of mouse phenome database.
| Phenotype name | BH FDR corrected P-value | Genes with the term |
|---|---|---|
| 0.023 | mcm4, npat, thoc1, bap1, dnmt1, yy1, hdac1 | |
| Increased embryonic tissue cell apoptosis | 0.028 | thoc1, dnmt1 |
| Prenatal lethality | 0.012 | mcm3, mcm4, thoc1, bap1, dnmt1, yy1, sin3a, hdac1 |
| Embryonic lethality, complete penetrance | 0.007 | mcm4, dnmt1, yy1, hdac1 |
| Embryonic lethality between implantation andsomite formation, complete penetrance | 0.036 | mcm4, sin3a |
| Increased hemolymphoid system tumor incidence | 0.007 | mcm4, esr2, h2afx |
| Increased T cell derived lymphoma incidence | 0.006 | mcm4, h2afx |
| Abnormal cell proliferation | 0.022 | mcm3, mcm4, dnmt1, esr2, h2afx, hdac1 |
| Decreased cell proliferation | 0.012 | mcm3, mcm4, dnmt1, h2afx, hdac1 |
| Chromosomal instability | 0.018 | mcm4, h2afx |
| Abnormal dopamine level | 0.014 | esr2, pnkd |
Figure 4Whole mount in situ hybridization analysis for temporal and spatial expression of the bap1, dnmt1, thoc1, cry3a, and udu genes during zebrafish early development. WISH of (a–d’) bap1, (e–h’) dnmt1, (i–l’) thoc1, (m–p’) cry3a, and (q–t’) udu expression at 24 hpf (a,b,e,f,i,j,m,n,q,r) and 72 hpf (c,d’,g,h’,k,l’,o,p’,s,t’) embryos. Black arrowhead indicates the pronephric duct (q). Rhombomere boundaries are indicated by black lines (r). Black asterisks indicate otic vesicles (f,j,n,r). Red arrows indicate olfactory sensory epithelium (c,k). Dashed rectangles in (d,h,l,p,t) are shown as enlarged images in (d’,h’,l’,p’,t’), respectively. Black arrows indicate neuromasts of the posterior lateral line (d’,h’,l’,p’,t’) and white dash lines indicate notochord (t’). Flat mount of WISH samples: (b,f,j,n,r). All embryos are oriented with anterior to the left.